Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea
17 de junio de 2026 actualizado por: Nisa Nur Demirtaş, Ataturk University
Effect of Emotional Freedom Techniques on Pain Intensity, Pain Catastrophizing, and Functional-Emotional Impact in Nursing Students With Primary Dysmenorrhea
This study will examine whether Emotional Freedom Techniques (EFT) can reduce pain intensity, pain catastrophizing, and functional-emotional impact in nursing students with primary dysmenorrhea.
Eligible participants will be randomly assigned to an intervention group or a control group.
The intervention group will receive EFT-based support, and the control group will continue their usual coping practices.
Study outcomes will be measured before the intervention, after the intervention, and at follow-up.
This study may provide evidence for a safe, non-pharmacological approach to support students with primary dysmenorrhea.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
92
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Being enrolled in a nursing program,
- Being 18 years of age or older
- Having had a regular menstrual cycle within the last six months
- Experiencing primary dysmenorrhea during the last three menstrual cycles
- Reporting moderate to severe pain according to the Visual Analog Scale (VAS: 4-10)
- Voluntary participation in the study
- Providing written informed consent
Exclusion Criteria:
- Having a diagnosed gynecological disease that may cause secondary dysmenorrhea (endometriosis, adenomyosis, uterine fibroids, pelvic inflammatory disease, etc.)
- Having chronic pain syndrome
- Receiving regular treatment or taking psychiatric medication due to a psychiatric diagnosis
- Applying another pharmacological or non-pharmacological intervention that may affect pain perception during the research process,
- Taking the course Obstetrics, Gynecology and Women's Health Nursing • Receiving/having received emotional freedom technique training,
- Having previously received training in this technique or regularly using it
- Having a cognitive or sensory problem that prevents communication or completing data collection forms
- Not completing the application protocol
- Incomplete completion of data collection forms
- Wishing to withdraw from the research
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Participants in the experimental group will receive a structured Emotional Freedom Techniques (EFT)-based nursing intervention.
The intervention will include an individual preparation and education session 5-7 days before the expected menstruation, followed by a guided EFT session on the first day of menstrual pain.
Participants will also be encouraged to perform self-application 1-2 times on the same day.
|
The intervention consists of a structured Emotional Freedom Techniques (EFT)-based nursing intervention designed for nursing students with primary dysmenorrhea.
It includes an individual preparation and education session conducted 5-7 days before the expected menstruation, during which pain-related thoughts, emotions, and bodily awareness are identified and individualized setup statements are developed.
A guided EFT session is then conducted on the first day of menstrual pain.
During this session, participants focus on dysmenorrhea-related distress while repeating the individualized setup statements and following the structured EFT sequence under researcher guidance.
Pain intensity and subjective distress are assessed before and after the guided session.
Participants are also advised to repeat the EFT self-application 1-2 times on the same day.
|
|
Sin intervención: Control Grup
Participants in the control group will not receive the EFT-based nursing intervention during the study period and will continue their usual coping methods for menstrual pain without any additional structured support.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Intensity
Periodo de tiempo: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Pain intensity will be assessed using the Visual Analog Scale (VAS).
Participants will rate the most severe menstrual pain experienced during the relevant menstrual cycle on a 0-10 scale, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
|
Pain Catastrophizing
Periodo de tiempo: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS).
Total scores range from 0 to 52.
Higher scores indicate greater pain catastrophizing and therefore a worse outcome.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
|
Functional-Emotional Impact
Periodo de tiempo: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Functional-emotional impact will be assessed using the Functional and Emotional Dysmenorrhea Scale (FEDS).
Total scores range from 14 to 70.
Higher scores indicate greater functional and emotional impact of dysmenorrhea and therefore a worse outcome.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
19 de junio de 2026
Finalización primaria (Estimado)
19 de octubre de 2026
Finalización del estudio (Estimado)
19 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
12 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
17 de junio de 2026
Publicado por primera vez (Actual)
22 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
22 de junio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
17 de junio de 2026
Última verificación
1 de junio de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- B.30.2.ATA.0.01.00/252
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .